You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

360 Results
Chercheur, Recherche en matière de surveillance, Soins aigus et hospitaliers, Santé Ontario todd.norwood@ontariohealth.ca  
Drug
Other Name(s): Imjudo®
Apr 2024
Drug
Other Name(s): Herceptin® , Kanjinti™; Ogivri™; Trazimera™; Herzuma®; Ontruzant®
Dec 2024
Drug
Other Name(s): Tecvayli®
Jan 2025
Document
Guidelines and Advice
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Palliative
Funding:
New Drug Funding Program
    Panitumumab - In Combination with Chemotherapy for Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
New Drug Funding Program
    Panitumumab - First-Line Treatment for Left-Sided Metastatic Colorectal Cancer
Jan 2025
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma
Jan 2025
Drug
Other Name(s): Trecondyv®
Jan 2025
The objective of the Medical Physics Residency Program is to train medical physicists to perform duties competently, professionally and safely in a...

Pages